Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition

Brazilian Journal of Infectious Diseases

Volumn 20, Issue 1, 2016, Pages 81-90

  Barros, Eliana Nogueira Castro de ^a   Cintra, Otavio ^a   Rossetto, Erika ^b   Freitas, Laís ^c   Colindres, Romulo ^a  

^a GSK   (Brazil)

^b INOVATEC   (Brazil)

^c Shift Gestão de Serviços   (Brazil)

Author keywords

Co circulation; Influenza B; Influenza vaccines; Mismatch

Indexed keywords

INFLUENZA VACCINE;

BRAZIL; CAUSAL ATTRIBUTION; DISEASE SURVEILLANCE; EPIDEMIC; HUMAN; INFECTION PREVENTION; INFLUENZA B; INFLUENZA B VIRUS; INFLUENZA VACCINATION; NONHUMAN; SEASONAL VARIATION; SHORT SURVEY; VIRUS DETECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; IMMUNOLOGY; INFLUENZA, HUMAN; SEASON; VACCINATION;

BRAZIL; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEASONS; VACCINATION;

EID: 84957436551     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2015.09.009     Document Type: Short Survey

References (52)

1. Meier C.R., Napalkov P.N., Wegmuller Y., Jefferson T., Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000, 19:834-842.
2. Karve S., Meier G., Davis K.L., Misurski D.A., Wang C.C. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage. Vaccine 2013, 31(33):3370-3388. 10.1016/j.vaccine.2013.04.081.
3. Daley A.J., Nallusamy R., Isaacs D. Comparison of influenza A and influenza B virus infection in hospitalized children. J Paediatr Child Health 2000, 36(4):332-335.
4. Paul Glezen W. Editorial commentary: changing epidemiology of influenza B virus. Clin Infect Dis 2014, 59(11):1525-1526. 10.1093/cid/ciu668.
5. Centers for Disease Control and Prevention: epidemiology and prevention of vaccine-preventable diseases 2011, 151-172. Public Health Foundation. 12th ed. W. Atkinson, S. Wolfe, J. Hamborsky (Eds.).
6. World Health Organization. Influenza (Seasonal). Available at: [accessed 28.12.14]. http://www.who.int/mediacentre/factsheets/fs211/en/.
7. WHO position paper: influenza vaccines. Wkly Epidemiol Rec 2005, 19. World Health Organization.
8. Skowronski D.M., Masaro C., Kwindt T.L., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25:2842-2851. 10.1016/j.vaccine.2006.10.002.
9. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25(15):6852-6862. 10.1016/j.vaccine.2007.07.027.
10. Heikkinen T., Ikonen N., Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis 2014, 10.1093/cid/ciu664.
11. Matias G., Taylor R., Haguinet F., Schuck-Paim C., Lustig R., Shinde V. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses 2014, 8(5):507-515. 10.1111/irv.12258.
12. Savy V., Ciapponi A., Bardach A., et al. Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis. Influenza Other Respir Viruses 2013, 7(6):1017-1032. 10.1111/irv.12036.
13. Brasil. Ministério da Saúde Departamento de Informática do SUS (DATASUS). [Internet]. Available at [accessed 28.12.14]. http://www2.datasus.gov.br/DATASUS/index.php?area=02.
14. Luna E.J., Gattas V.L. Effectiveness of the Brazilian influenza vaccination policy, a systematic review. Rev Inst Med Trop Sao Paulo 2010, 52(4):175-181.
15. Oliveira J.F., Boing A.F., Waldman E.A., Antunes J.L.F. Ecological study on mortality from influenza and pneumonia before and after influenza vaccination in the Northeast and South of Brazil. Cadernos de Saúde Pública 2013, 29:2535-2545.
16. World Health Organization WHO recommendations on the composition of influenza virus vaccines 2014, Influenza, Available at http://www.who.int/influenza/vaccines/virus/recommendations/en/index.html [accessed 28.04.15].
17. Brasil. Ministério da Saúde Secretaria de Vigilância em Saúde. oordenação Geral de Doenças Transmissíveis. Situação Epidemiológica/Dados. [Internet]. Available at [accessed 28.12.14]. http://portalsaude.saude.gov.br/index.php/situacao-epidemiologica-dados-influenza.
18. World Health Organization. Influenza vaccine viruses and reagents. [Internet]. Available at [accessed 28.12.14]. http://www.who.int/influenza/vaccines/virus/en/.
19. World Health Organization. Influenza, FluNet. Available at [accessed 28.12.14]. http://www.who.int/influenza/gisrs_laboratory/flunet/en/.
20. Annual conference on vaccine research. Available at [accessed 28.12.14]. http://www.nfid.org/professional-education/conferences.
21. ESWI influenza conference. Available at http://www.eswiconference.org/core/.
22. European Society for Paediatric Infectious Diseases. Available at [accessed 28.12.14]. http://www.espid.org/.
23. International Congress of Virology. Available at [accessed 28.12.14]. http://www.iums.org/index.php/congresses.
24. International Congress on Infectious Diseases. Available at [accessed 28.12.14]. http://www.isid.org/.
25. International Society of Vaccines Congress. Available at [accessed 28.12.14]. http://www.isv-online.org/.
26. Options for the control of influenza. Available at [accessed 28.12.14]. http://optionsviii.controlinfluenza.com/.
27. Sociedad Latinoamericana de Infectología Pediátrica. Available at [accessed 28.12.14]. http://www.slipe.org/default.asp.
28. World Congress of Epidemiology. Available at [accessed 28.12.14]. http://ieaweb.org/.
29. World Society for Pediatric Infectious Diseases. Available at [accessed 28.12.14]. http://www.pids.org/index.php.
30. Bellei N., Carraro E., Perosa A., Granato C. Patterns of influenza infections among different risk groups in Brazil. Braz J Infect Dis 2007, 11(4):399-402.
31. Bellei N., Carraro E., Perosa A., Watanabe A., Arruda E., Granato C. Acute respiratory infection and influenza-like illness viral etiologies in Brazilian adults. J Med Virol 2008, 80(10):1824-1827. 10.1002/jmv.21295.
32. Borborema S.E., Silva D.B., Silva K.C., et al. Molecular characterization of influenza B virus outbreak on a cruise ship in Brazil 2012. Rev Inst Med Trop Sao Paulo 2014, 56(3):185-189.
33. Carraro E., Neto D.F., Benfica D., SittaPerosa A.H., Granato C.F., Bellei N.C. Applications of a duplex reverse transcription polymerase chain reaction and direct immunofluorescence assay in comparison with virus isolation for detection of influenza A and B. Diagn Microbiol Infect Dis 2007, 57(1):53-57. 10.1016/j.diagmicrobio.2006.11.004.
34. Coelho M.C., Tsuchiya L.R., Nogueira M.B., et al. Impact of respiratory infections by influenza viruses A and B in pediatrics patients from Federal University of Parana, Brazil. Braz J Infect Dis 2007, 11(2):220-223.
35. Fernandes E.G., de Souza P.B., de Oliveira M.E., et al. Influenza B outbreak on a cruise ship off the Sao Paulo Coast, Brazil. J Travel Med 2014, 21(5):298-303. 10.1111/jtm.12132.
36. Freitas F.T. Sentinel surveillance of influenza and other respiratory viruses, Brazil, 2000-2010. Braz J Infect Dis 2013, 17(1):62-68. 10.1016/j.bjid.2012.09.001.
37. Paiva T.M., Benega M.A., Silva D.B., et al. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in Sao Paulo, Brazil, 1996-2012: implications for vaccine composition strategy. J Med Virol 2013, 85(11):1983-1989. 10.1002/jmv.23684.
38. Ribeiro R., Dutra M., Higa L., de Oliveira U., Stephens P., Portes S. Etiologia viral das infecções respiratórias agudas em população pediátrica no Instituto Fernandes Figueira/FIOCRUZ/RJ. J Bras Patol Med Lab 2011, 47(5):519-527.
39. Silva P. Análise filogenética e padronização da técnica de Eletroforese em gel com gradientes desnaturantes (DGGE) para caracterização das linhagens do vírus Influenza B identificadas durante as epidemias de 2004 a 2008 2010, 134. Instituto Oswaldo Cruz, Rio de Janeiro.
40. Thomazelli L.M., Vieira S., Leal A.L., et al. Vigilância de oito vírus respiratórios em amostras clínicas de pacientes pediátricos no sudeste do Brasil. J Pediatr 2007, 83:422-428.
41. Vidal L.R., Siqueira M.M., Nogueira M.B., et al. The epidemiology and antigenic characterization of influenza viruses isolated in Curitiba, South Brazil. Mem Inst Oswaldo Cruz 2008, 103(2):180-185.
42. Oliveira M., Motta F., Soares S., Resende P., Carney S., Costa J. Mismatch between vaccine strains and circulating influenza B viruses in different regions of Brazil: 2001-2013. Options for the control of influenza. Cape Town 2013, 382. Available at http://optionsviii.controlinfluenza.com/ [accessed 28.12.14].
43. Paiva T., Benega M., Silva D., Santos K., Pereira J., Sasaki N. Influenza virus surveillance conducted by the Institute Adolfo Lutz, São Paulo, SP, Brazil: 2013 influenza season. Options for the control of influenza. Cape Town 2013, 599. Available at http://optionsviii.controlinfluenza.com/ [accessed 28.12.14].
44. Perosa A., Bellei N. Influenza B circulation during twelve influenza seasons (2001-2013) in a tertiary hospital in Sao Paulo, Brazil. Options for the control of influenza. Cape Town 2013, 637. [Internet]. Available at http://optionsviii.controlinfluenza.com/ [accessed 28.12.14].
45. Lee B.Y., Bartsch S.M., Willig A.M. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 2012, 30(52):7443-7446. 10.1016/j.vaccine.2012.10.025.
46. Lo Y.C., Chuang J.H., Kuo H.W., et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLOS ONE 2013, 8(3):e58222. 10.1371/journal.pone.0058222.
47. Baguelin M., Flasche S., Camacho A., Demiris N., Miller E., Edmunds W.J. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 2013, 10(10):e1001527. 10.1371/journal.pmed.1001527.
48. Motta F.C., Siqueira M.M., Lugon A.K., Straliotto S.M., Fernandes S.B., Krawczuk M.M. The reappearance of Victoria lineage influenza B virus in Brazil, antigenic and molecular analysis. J Clin Virol 2006, 36(3):208-214. 10.1016/j.jcv.2006.03.008.
49. Jian J.W., Lai C.T., Kuo C.Y., et al. Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics. Virus Res 2008, 131(2):243-249. 10.1016/j.virusres.2007.09.014.
50. Shaw M.W., Xu X., Li Y., et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002, 303(1):1-8.
51. Paul Glezen W., Schmier J.K., Kuehn C.M., Ryan K.J., Oxford J. The burden of influenza B: a structured literature review. Am J Public Health 2013, 103(3):e43-e51. 10.2105/ajph.2012.301137.
52. World Health Organization. Influenza Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. Available at [accessed 28.12.14]. http://www.who.int/influenza/vaccines/virus/recommendations/2015_south/en/.